home.social

#medicalresearch — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #medicalresearch, aggregated by home.social.

  1. DATE: May 14, 2026 at 11:30AM
    SOURCE: PSYCHIATRIC TIMES

    Direct article link at end of text block below.

    Our Schizophrenia Special Report starts releasing today.

    Read the introduction by Special Report Chair Peter F. Buckley, MD, now: t.co/eqRcZR1SG4 t.co/eQ0YLqHabO

    Here are any URLs found in the article text:

    t.co/eqRcZR1SG4

    t.co/eQ0YLqHabO

    Articles can be found by scrolling down the page at Articles can be found at psychiatrictimes.com/news".

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #Schizophrenia #SpecialReport #PeterBuckley #MentalHealthNews #MedicalResearch

  2. Soligenix reports positive Phase 2 trial results for SGX945 in treating Behçet's disease, offering new hope for patients with rare inflammatory condition #MedicalResearch #RareDiseases

  3. Soligenix reports positive Phase 2 trial results for SGX945 in treating Behçet's disease, offering new hope for patients with rare inflammatory condition #MedicalResearch #RareDiseases

  4. Soligenix reports positive Phase 2 trial results for SGX945 in treating Behçet's disease, offering new hope for patients with rare inflammatory condition #MedicalResearch #RareDiseases

  5. Soligenix reports positive Phase 2 trial results for SGX945 in treating Behçet's disease, offering new hope for patients with rare inflammatory condition #MedicalResearch #RareDiseases

  6. Soligenix reports positive Phase 2 trial results for SGX945 in treating Behçet's disease, offering new hope for patients with rare inflammatory condition #MedicalResearch #RareDiseases

  7. Soligenix reports positive Phase 2 trial results for SGX945 in treating Behçet's disease, offering new hope for patients with rare inflammatory condition #MedicalResearch #RareDiseases

  8. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  9. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  10. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  11. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  12. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  13. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  14. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  15. Michigan State University reveals inflammation suppression might delay healing, challenging traditional postoperative pain management strategies. New research suggests rethinking current medical protocols. #MedicalResearch #Healthcare

  16. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  17. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  18. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  19. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  20. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  21. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  22. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  23. Soligenix advances groundbreaking solutions for Cutaneous T-Cell Lymphoma, targeting early detection and innovative treatment strategies for this challenging rare disease #MedicalResearch #Oncology

  24. Penn State College of Medicine partners with Targepeutics to advance promising DIPG treatment research, offering new hope for pediatric brain cancer patients. Innovative collaboration seeks breakthrough in challenging childhood cancer therapy. #PediatricCancer #MedicalResearch

  25. Penn State College of Medicine partners with Targepeutics to advance promising DIPG treatment research, offering new hope for pediatric brain cancer patients. Innovative collaboration seeks breakthrough in challenging childhood cancer therapy. #PediatricCancer #MedicalResearch

  26. Penn State College of Medicine partners with Targepeutics to advance promising DIPG treatment research, offering new hope for pediatric brain cancer patients. Innovative collaboration seeks breakthrough in challenging childhood cancer therapy. #PediatricCancer #MedicalResearch

  27. UNC researchers develop promising combo therapy targeting glioblastoma, showing unprecedented results in preclinical studies. Innovative approach may transform brain cancer treatment strategies. #MedicalResearch #CancerTreatment

  28. UNC researchers develop promising combo therapy targeting glioblastoma, showing unprecedented results in preclinical studies. Innovative approach may transform brain cancer treatment strategies. #MedicalResearch #CancerTreatment

  29. UNC researchers develop promising combo therapy targeting glioblastoma, showing unprecedented results in preclinical studies. Innovative approach may transform brain cancer treatment strategies. #MedicalResearch #CancerTreatment

  30. Free omega-3 testing to be introduced in SA for pregnant women in a bid to prevent preterm birth

    South Australian women in the early stages of pregnancy will now receive free omega-3 blood tests as part…
    #NewsBeep #News #Health #Antenatal #AU #Australia #baby #birth #bloodtests #FattyAcids #MedicalResearch #omega-3 #Pathology #pregnancy #preterm #WomensHealth #WorldFirst
    newsbeep.com/au/667856/